[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100520705":3},{"organization":4,"armGroups":7,"interventions":10,"overallOfficials":10,"centralContacts":12,"locations":18,"responsibleParty":163,"collaborators":10,"id":165,"slug":10,"hasResults":166,"nctId":167,"briefTitle":168,"officialTitle":168,"acronym":10,"eligibilityCriteria":169,"healthyVolunteers":166,"sex":170,"minAge":171,"maxAge":10,"enrollmentInfo":172,"targetDuration":10,"studyType":175,"phases":10,"briefSummary":176,"conditions":177,"keywords":10,"overallStatus":21,"whyStopped":10,"lastUpdateSubmitDate":181,"lastUpdatePostDateStruct":182,"startDateStruct":185,"completionDateStruct":187,"leadSponsor":189,"locationsCount":190},{"fullName":5,"class":6},"Bausch & Lomb Incorporated","INDUSTRY",[8],{"label":9,"type":10,"description":11,"interventionNames":10},"IC-8 Apthera intraocular lens (IOL) Group",null,"Patients previously implanted with the IC-8 Apthera intraocular lens (IOL) and who have developed posterior capsular opacification (PCO) which requires treatment with Nd:YAG laser capsulotomy.",[13],{"name":14,"role":15,"phone":16,"phoneExt":10,"email":17},"Jennifer Laskowski","CONTACT","8183699137","jennifer.laskowski@bausch.com",[19,32,45,55,64,74,84,94,104,114,124,133,143,153],{"facility":20,"status":21,"city":22,"state":23,"zip":24,"country":25,"cosmosGeoPoint":26,"geoPoint":31,"contacts":10},"Trinity Research Group, LLC","RECRUITING","Dothan","Alabama","36301","United States",{"type":27,"coordinates":28},"Point",[29,30],-85.39049,31.22323,{"lat":30,"lon":29},{"facility":33,"status":21,"city":34,"state":35,"zip":36,"country":25,"cosmosGeoPoint":37,"geoPoint":41,"contacts":42},"Feinerman Vision Center","Newport Beach","California","92663",{"type":27,"coordinates":38},[39,40],-117.92895,33.61891,{"lat":40,"lon":39},[43],{"name":44,"role":15,"phone":10,"phoneExt":10,"email":10},"OD",{"facility":46,"status":21,"city":47,"state":48,"zip":49,"country":25,"cosmosGeoPoint":50,"geoPoint":54,"contacts":10},"Argus Research Center","Cape Coral","Florida","33909",{"type":27,"coordinates":51},[52,53],-81.94953,26.56285,{"lat":53,"lon":52},{"facility":56,"status":21,"city":57,"state":48,"zip":58,"country":25,"cosmosGeoPoint":59,"geoPoint":63,"contacts":10},"Stephenson Eye Associates","Venice","34285",{"type":27,"coordinates":60},[61,62],-82.45426,27.09978,{"lat":62,"lon":61},{"facility":65,"status":21,"city":66,"state":67,"zip":68,"country":25,"cosmosGeoPoint":69,"geoPoint":73,"contacts":10},"Virdi Eye Clinic and Laser Vision Center","Rock Island","Illinois","61201",{"type":27,"coordinates":70},[71,72],-90.57875,41.50948,{"lat":72,"lon":71},{"facility":75,"status":21,"city":76,"state":77,"zip":78,"country":25,"cosmosGeoPoint":79,"geoPoint":83,"contacts":10},"Price Vision Group","Indianapolis","Indiana","46260",{"type":27,"coordinates":80},[81,82],-86.15804,39.76838,{"lat":82,"lon":81},{"facility":85,"status":21,"city":86,"state":87,"zip":88,"country":25,"cosmosGeoPoint":89,"geoPoint":93,"contacts":10},"Grene Vision Group","Wichita","Kansas","67206",{"type":27,"coordinates":90},[91,92],-97.33754,37.69224,{"lat":92,"lon":91},{"facility":95,"status":21,"city":96,"state":97,"zip":98,"country":25,"cosmosGeoPoint":99,"geoPoint":103,"contacts":10},"Oakland Eye","Birmingham","Michigan","48009",{"type":27,"coordinates":100},[101,102],-83.21132,42.5467,{"lat":102,"lon":101},{"facility":105,"status":21,"city":106,"state":107,"zip":108,"country":25,"cosmosGeoPoint":109,"geoPoint":113,"contacts":10},"Vance Thompson Vision - Omaha","Omaha","Nebraska","68137",{"type":27,"coordinates":110},[111,112],-95.94043,41.25626,{"lat":112,"lon":111},{"facility":115,"status":21,"city":116,"state":117,"zip":118,"country":25,"cosmosGeoPoint":119,"geoPoint":123,"contacts":10},"Eye Associates of New Jersey","Dover","New Jersey","07801",{"type":27,"coordinates":120},[121,122],-74.5621,40.88399,{"lat":122,"lon":121},{"facility":125,"status":21,"city":126,"state":117,"zip":127,"country":25,"cosmosGeoPoint":128,"geoPoint":132,"contacts":10},"Northern New Jersey Eye Institute","South Orange","07079",{"type":27,"coordinates":129},[130,131],-74.26126,40.74899,{"lat":131,"lon":130},{"facility":134,"status":21,"city":135,"state":136,"zip":137,"country":25,"cosmosGeoPoint":138,"geoPoint":142,"contacts":10},"Ophthalmic Partners, PC","Bala-Cynwyd","Pennsylvania","19004",{"type":27,"coordinates":139},[140,141],-75.23407,40.00761,{"lat":141,"lon":140},{"facility":144,"status":21,"city":145,"state":146,"zip":147,"country":25,"cosmosGeoPoint":148,"geoPoint":152,"contacts":10},"Berkeley Eye Center","Sugar Land","Texas","77478",{"type":27,"coordinates":149},[150,151],-95.63495,29.61968,{"lat":151,"lon":150},{"facility":154,"status":21,"city":155,"state":156,"zip":157,"country":25,"cosmosGeoPoint":158,"geoPoint":162,"contacts":10},"Utah Eye Centers","Bountiful","Utah","84010",{"type":27,"coordinates":159},[160,161],-111.88077,40.88939,{"lat":161,"lon":160},{"type":164,"investigatorFullName":10,"investigatorTitle":10,"investigatorAffiliation":10,"oldNameTitle":10,"oldOrganization":10},"SPONSOR","100520705",false,"NCT06060041","IC-8 Apthera IOL New Enrollment Post Approval Study","Inclusion Criteria:\n\n* 22 years of age or older, any race and any gender;\n* Posterior capsule opacification (PCO) requiring treatment in the IC-8 Apthera IOL eye\n* Able to comprehend and have signed a statement of informed consent;\n* Availability, willingness, ability and sufficient cognitive awareness to comply with examination procedures and study visits;\n* Clear intraocular media in both eyes;\n* Preoperative corneal astigmatism ≤1.5 D in the IC-8 Apthera IOL eye prior to IC-8 Apthera implantation;\n* Prior IC-8 Apthera IOL implantation in one eye and a monofocal\u002Fmonofocal toric IOL in the other eye in accordance with the directions for use (DFU) for each IOL.\n\nExclusion Criteria:\n\n* Pharmacologically dilated pupil size less than 7.0 mm in the IC-8 Apthera IOL eye;\n* Irregular astigmatism in either eye;\n* History of retinal disease;\n* Active or recurrent anterior segment pathology;\n* Presence of ocular abnormalities;\n* Diagnosis of dry eye in which patients are unable to maintain eye comfort or adequate vision even with dry eye treatment;\n* Previous corneal or intraocular surgery, except cataract surgery;\n* History of ocular trauma or ocular conditions expected to require retinal laser treatment or other surgical intervention;\n* Acute, chronic or uncontrolled systemic disease that would, in the opinion of the investigator, confound the outcomes of the study;\n* Patient is pregnant, plans to become pregnant, is lactating or has another condition associated with hormonal fluctuation that could lead to refractive changes and dry eye;\n* Concurrent participation or participation in any clinical trial up to 30 days prior to the first visit in the study.\n* Subjects who plan to be traveling, relocating or otherwise unavailable to attend any of the visits","ALL","22 Years",{"count":173,"type":174},435,"ESTIMATED","OBSERVATIONAL","The purpose of this study is to verify the post-market safety of the IC-8 Apthera IOL after the treatment of posterior capsular opacification (PCO), an expected complication related to IC-8 Apthera IOL implantation.",[178,179,180],"Cataract","Presbyopia","Posterior Capsule Opacification","2026-01-09",{"date":183,"type":184},"2026-01-12","ACTUAL",{"date":186,"type":184},"2023-09-08",{"date":188,"type":174},"2027-09-30",{"name":5,"class":6},14]